These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 19224282

  • 1. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J, Arbab D, Huan X, Vallböhmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R.
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [Abstract] [Full Text] [Related]

  • 2. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2005 Dec 01; 11(23):8341-7. PubMed ID: 16322294
    [Abstract] [Full Text] [Related]

  • 3. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS, Carvalho AL, Jeronimo C, Henrique R, Kim MM, Hoque MO, Chang S, Jiang WW, Koch W, Westra W, Sidransky D, Califano J.
    Laryngoscope; 2007 Aug 01; 117(8):1376-80. PubMed ID: 17592394
    [Abstract] [Full Text] [Related]

  • 4. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H, Iida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, Takagi Y, Enjoji M, Yamada H, Uetake H, Kojima K, Sugihara K.
    Oncol Rep; 2011 Feb 01; 25(2):513-8. PubMed ID: 21152877
    [Abstract] [Full Text] [Related]

  • 5. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC, Liu SS, Chan KY, Tam KF, Chan KL, Wong LC, Ngan HY.
    Oncol Rep; 2008 May 01; 19(5):1339-45. PubMed ID: 18425396
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Hokita S, Xi H, Higashi H, Baldus SE, Metzger R, Brabender J, Bollschweiler E, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM.
    Oncol Rep; 2005 Jun 01; 13(6):1241-6. PubMed ID: 15870949
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.
    J Am Coll Surg; 2005 Mar 01; 200(3):336-44. PubMed ID: 15737843
    [Abstract] [Full Text] [Related]

  • 8. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF, Kong FM, Xu Z, Yu SP, Sun FB, Zhang CS, Huang QX, Zhou XT, Song ZW.
    Hepatobiliary Pancreat Dis Int; 2007 Aug 01; 6(4):407-11. PubMed ID: 17690039
    [Abstract] [Full Text] [Related]

  • 9. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.
    Int J Oncol; 2005 Jun 01; 26(6):1493-500. PubMed ID: 15870861
    [Abstract] [Full Text] [Related]

  • 10. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R.
    Pathol Res Pract; 2010 Sep 15; 206(9):616-24. PubMed ID: 20630662
    [Abstract] [Full Text] [Related]

  • 11. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Metzger R, Miyazono F, Baldus SE, Neiss S, Brabender J, Schaefer H, Doerfler W, Bollschweiler E, Dienes HP, Mueller RP, Danenberg PV, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3794-9. PubMed ID: 15173087
    [Abstract] [Full Text] [Related]

  • 12. Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.
    Kim WS, Son HJ, Park JO, Song SY, Park C.
    Int J Mol Med; 2003 Dec 01; 12(6):827-30. PubMed ID: 14612952
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.
    Ye M, Li D, Zhou F, Guo Q, Xia B.
    Eur J Cancer Prev; 2012 May 01; 21(3):241-6. PubMed ID: 21979297
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer.
    Grimminger P, Vallböhmer D, Hoffmann A, Schulte C, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R, Brabender J.
    J Surg Oncol; 2009 Nov 01; 100(6):447-51. PubMed ID: 19653263
    [Abstract] [Full Text] [Related]

  • 16. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
    Prenzel KL, König A, Schneider PM, Schnickmann C, Baldus SE, Schröder W, Bollschweiler E, Dienes HP, Mueller RP, Izbicki JR, Hölscher AH.
    Ann Surg Oncol; 2007 Feb 01; 14(2):954-9. PubMed ID: 17103071
    [Abstract] [Full Text] [Related]

  • 17. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
    Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, Kostrzewa M, Buchholz E, Manegold C, Lahm H.
    Lung Cancer; 2006 Oct 01; 54(1):109-16. PubMed ID: 16893590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy.
    Lattario F, Furtado YL, Silveira FA, do Val IC, Almeida G, da Costa Carvalho Mda G.
    Arch Gynecol Obstet; 2008 Jun 01; 277(6):505-9. PubMed ID: 18026971
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.